Search

Haleon PLC

Închisă

Sector Sănătate

394.4 0.48

Rezumat

Modificarea prețului

24h

Curent

Minim

392.7

Maxim

397.2

Indicatori cheie

By Trading Economics

Venit

58M

423M

Vânzări

-144M

2.8B

P/E

Medie Sector

29.48

103.001

EPS

0.033

Randament dividend

1.275

Marjă de profit

14.491

EBITDA

-2M

687M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

-2.59 downside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.27%

7.76%

Data viitoare de dividende

19 sept. 2024

Statistici piață

By TradingEconomics

Capitalizare de piață

59M

35B

Deschiderea anterioară

393.92

Închiderea anterioară

394.4

Sentimentul știrilor

By Acuity

50%

50%

97 / 365 Clasament în Healthcare

Haleon PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

1 aug. 2024, 06:54 UTC

Câștiguri

Haleon Lifts Profit Guidance on Profit Rise

26 iun. 2024, 13:33 UTC

Achiziții, Fuziuni, Preluări

Haleon to Sell Nicotine-Quitting Aid Business for $634 Million -- Update

26 iun. 2024, 12:32 UTC

Achiziții, Fuziuni, Preluări

Haleon to Sell Nicotine-Quitting Aid Business for $634 Million

17 mai 2024, 06:24 UTC

Achiziții, Fuziuni, Preluări

GSK Sells Last Haleon Shares for $1.58 Billion

16 mai 2024, 16:46 UTC

Achiziții, Fuziuni, Preluări

GSK to Sell Remaining Stake in Haleon Valued at Around $1.27 Billion -- Update

16 mai 2024, 16:28 UTC

Achiziții, Fuziuni, Preluări

GSK to Sell Stake in Haleon Valued at About $1.61 Billion

1 aug. 2024, 13:08 UTC

Market Talk
Câștiguri

Haleon 1H Results Are Positive -- Market Talk

1 aug. 2024, 07:08 UTC

Market Talk
Câștiguri

Haleon's 1H Results Don't Surprise -- Market Talk

1 aug. 2024, 06:09 UTC

Câștiguri

Haleon Launches BuyBack Program Up to GBP185M

1 aug. 2024, 06:05 UTC

Câștiguri

Haleon Now Expects 2024 Operating Profit Growth to Grow High-Single Digit

1 aug. 2024, 06:04 UTC

Câștiguri

Haleon Had Seen Organic Revenue Growth of 4% to 6%

1 aug. 2024, 06:04 UTC

Câștiguri

Haleon Backs 2024 Organic Revenue Growth View

1 aug. 2024, 06:03 UTC

Câștiguri

Haleon Declares Interim Dividend of 2.0p per share

1 aug. 2024, 06:02 UTC

Câștiguri

Haleon 1H Adj EBIT Consensus GBP1.275B

1 aug. 2024, 06:02 UTC

Câștiguri

Haleon 1H Adj Oper Pft GBP1.29B

1 aug. 2024, 06:01 UTC

Câștiguri

Haleon 1H Organic Rev Growth Consensus 3.5%

1 aug. 2024, 06:01 UTC

Câștiguri

Haleon 1H Organic Rev Growth 3.5%

1 aug. 2024, 06:01 UTC

Câștiguri

Haleon 1H Revenue Consensus GBP5.69B

1 aug. 2024, 06:01 UTC

Câștiguri

Haleon 1H Rev GBP5.69B

26 iun. 2024, 11:54 UTC

Achiziții, Fuziuni, Preluări

Haleon: All Other 2024 Guidance Unchanged

26 iun. 2024, 11:54 UTC

Achiziții, Fuziuni, Preluări

Haleon: Sale Will Dilute 2024 Rev by 0.5%, Adj Oper Pft by 1%

26 iun. 2024, 11:52 UTC

Achiziții, Fuziuni, Preluări

Haleon: Sale Allow For NRT Exit Outside US, Trims Business Complexity

26 iun. 2024, 11:51 UTC

Achiziții, Fuziuni, Preluări

Haleon: Deal Expected to Complete Early 4Q

26 iun. 2024, 11:50 UTC

Achiziții, Fuziuni, Preluări

Haleon: Use of Proceeds Will Be in Line With Capital Allocation Priorities

26 iun. 2024, 11:49 UTC

Achiziții, Fuziuni, Preluări

Haleon: Deal Structure Upfront Cash GBP458M, GBP42M Performance-Based Payable

26 iun. 2024, 11:48 UTC

Achiziții, Fuziuni, Preluări

Haleon: Portfolio Includes Nicotinell, Nicabate, Habitrol and Thrive Available in Gum, Lozenge

26 iun. 2024, 11:47 UTC

Achiziții, Fuziuni, Preluări

Haleon: Deal Worth GBP500M With Additional Proceeds From Inventory Transfer

26 iun. 2024, 11:46 UTC

Achiziții, Fuziuni, Preluări

Haleon to Sell Non-US Nicotine Replacement Therapy Business to Dr. Reddy's Laboratories

17 mai 2024, 06:09 UTC

Achiziții, Fuziuni, Preluări

GSK Sells Last Haleon Shares for $1.58 Bln

16 mai 2024, 15:46 UTC

Achiziții, Fuziuni, Preluări

GSK PLC: Shares Are Equivalent to Around 4.2% of Haleon's Share Capital

Haleon PLC Așteptări

Obiectiv de preț

By TipRanks

-2.59% jos

Prognoză pe 12 luni

Medie 382.9 GBX  -2.59%

Maxim 450 GBX

Minim 300 GBX

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruHaleon PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

10 ratings

5

Cumpărare

4

Păstrare

1

Vânzare

Sentiment

By Acuity

97 / 365 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

EBITDA

Profit operațional

$

Despre Haleon PLC

Haleon plc is a consumer healthcare company. The Company’s product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.